Venmax Drugs & Pharmaceuticals Ltd. - Research Center
531015 VENMAX Group (XT) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | -5.89 | -5.95 | -6.18 | -8.03 | -7.86 |
| Loan funds | |||||
| Secured loans | 0.35 | 0.35 | 0.35 | 2.33 | 2.52 |
| Unsecured loans | - | - | - | - | - |
| Total | -0.30 | -0.36 | -0.59 | -0.46 | -0.10 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 0.07 | 0.09 | 0.11 | 0.11 | 0.11 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | - | 0.01 | 0.03 | 0.02 | 0.01 |
| Net block | 0.07 | 0.07 | 0.08 | 0.09 | 0.10 |
| Capital work-in-progress | - | - | - | - | - |
| Investments | - | - | - | - | - |
| Net current assets | |||||
| Current assets, loans & advances | 0.02 | 0.14 | 0.13 | 0.22 | 0.35 |
| Less : current liabilities & provisions | 0.38 | 0.57 | 0.80 | 0.76 | 0.56 |
| Total net current assets | -0.36 | -0.44 | -0.67 | -0.55 | -0.21 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | -0.30 | -0.36 | -0.59 | -0.46 | -0.10 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | - | - | - | - | - |
| Number of equity sharesoutstanding (Lacs) | 52.39 | 52.39 | 52.39 | 52.39 | 52.39 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis